1Al-Salami A., 2Saleh Al-S., 2Aulaqi S., 3Al-Arami A
1Department of Surgery, Faculty of Medicine and Health Sciences, University of Sana’a
2Pathohistology department, Faculty of Medicine and Health Sciences, University of Sana’a
3Pathohistology department, Faculty of Medicine and Health Sciences, University of Sana’a
There are three diseases most often discussed when considering prostate health: benign prostatic hyperplasia (BPH), Infections and inflammation of the prostate (prostatitis), and prostate cancer.
Benign prostatic hyperplasia (BPH) assigns most of men after the age of fifty and represents the most common urologic disease among elderly males (1). BPH is histologically defined as an overgrowth of the epithelial and stromal cells from the transition zone and periurethral area. stromal and epithelial elements, either alone or in combination, can give rise to hypertrophic nodule (3).
Incidence of histological BPH could be over 70% at 60 years old and over 90% at 70 years old (2). But histological BPH doesn’t systematically lead to clinical manifestations. BPH symptoms can range over a wide scale from minimal bother to urinary retention and renal failure (4-6).
Minimal procedure such as transurethral resection of the prostate (TURP) is a Gold standard treatments method to relieve the lower urinary tract obstruction and avoid BPH complications. TURP is a common procedure and about 20% of the male population is likely to undergo this operation in their life time (7). But the facility of TURP is not freely available in Yemen, only available in major